|Description||Alfuzosin is a pharmaceutical drug of the alpha-1 blocker class. It works by relaxing the muscles in the prostate and bladder neck. It is used to treat benign prostatic hyperplasia (BPH). It offers an alternative to prostatectomy in patients who require surgery but are unfit for this treatment, and in patients requiring symptomatic relief while awaiting surgery. It is marketed in the United States by Sanofi Aventis under the brand name Uroxatral. It was approved by the FDA for treatment of BPH in June 2003. It has been approved the listing.|
|Solubility||DMSO 85 mg/mL (199 mM); Water 85 mg/mL (199 mM)|
|Application||Alfuzosin is used to treat benign prostatic hyperplasia (BPH).|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Quantity||Grams to Kilograms|
|Melting Point||178-180 °C|
|Density||1.272±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr|
|Current Developer||Alfuzosin is marketed in the United States by Sanofi Aventis under the brand name Uroxatral. It was approved by the FDA for treatment of BPH in June 2003. It has been approved the listing.|
Clorprenaline is a beta-adrenergic receptor agonist.
Lerimazoline is an α-adrenergic receptor agonist. It inhibits secretion of nasal mucus. It causes hypertension. It is common used in the form of hydrochloride.
Yohimbine, an indolalkylamine alkaloid, blocks presynaptic alpha-2 adrenergic receptors. IC50= 0.6 μM Ki: 1.05 nM, alphaα2Areceptor
Scopine is the metabolite of anisodine, which is a α1-adrenergic receptor agonist and used in the treatment of acute circulatory shock.
Epinephrine Bitartrate is an alpha- and beta-adrenergic receptor stimulator. It can be used for the treatment of asthma and cardiac failure via stimulating the ...
CGP 12177 hydrochloride
CGP 12177 hydrochloride is a partial agonist of β3-adrenoceptors, and also an antagonist of β1- and β2-adrenoceptors (Ki = 0.9, 4 and 88 nM for β1, β2 and β3 re...
Phenylethanolamine A is a novel beta-agonist naturally occuring in animal species.
Brombuterol is found to be a novel β-adrenergic agonist that can increase the meat-to-fat ratio but it is banned in animal feeds.